Bariatric surgery improves outcomes of hospitalizations for acute heart failure: a contemporary, nationwide analysis

Mabeza, Russyan Mark; Richardson, Shannon; Vadlakonda, Amulya; Chervu, Nikhil; Roberts, Jacob; Yetasook, Amy; Benharash, Peyman

doi:10.1016/j.soard.2022.12.027

Cited by 10 publications

(5 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Section: Bariatric Surgeriesmentioning

confidence: 70%

“…In a case-control study evaluating bariatric surgery in patients with IBD (194 Crohn's disease, 306 ulcerative colitis), compared to non-IBD controls, patients with Crohn's disease had higher readmission rates postsurgery, and patients with ulcerative colitis faced more serious complications after RYGB but not after sleeve gastrectomy. There were no significant differences noted in weight loss or health-related quality of life postoperatively [46]. In another case--control study, patients with IBD who underwent bariatric surgery ( n = 25) were matched with those who did not ( n = 25), and it was found that those who underwent bariatric surgery not only achieved a median BMI reduction of 12.2 kg/m 2 , but also experienced less frequent IBD-related surgeries and corticosteroid use compared to their nonsurgical counterparts.…”

Section: Bariatric Surgeriesmentioning

confidence: 72%

“…In a study assessing data from 719 270 patients undergoing laparoscopic sleeve gastrectomy or Roux-en-Y gastric bypass (RYGB) between 2016 and 2019, patients with IBD were more likely to have higher Elixhauser comorbidity index and choose sleeve gastrectomy. While patients with IBD had increased odds of bowel obstruction post-RYGB, bariatric surgery appeared overall safe and effective as a weight loss intervention for patients with IBD [46]. In a case-control study evaluating bariatric surgery in patients with IBD (194 Crohn's disease, 306 ulcerative colitis), compared to non-IBD controls, patients with Crohn's disease had higher readmission rates postsurgery, and patients with ulcerative colitis faced more serious complications after RYGB but not after sleeve gastrectomy.…”

Section: Bariatric Surgeriesmentioning

confidence: 97%

See 2 more Smart Citations

Reviewing the impact of obesity on inflammatory bowel disease and considerations for optimizing management

Ghusn,

Loftus,

Johnson

2024

Current Opinion in Gastroenterology

View full text Add to dashboard Cite

Purpose of review This review examines the complex relationship between obesity and inflammatory bowel disease (IBD), encompassing their potentially shared pathogenesis, the impact of obesity on the natural history and treatment outcomes of IBD, and the management of obesity in the patient with IBD. Recent findings Obesity represents a state of chronic inflammation that may not only contribute to IBD pathogenesis, but also influence disease progression, complications, and response to treatment. Increased visceral adiposity may carry negative prognostic implications for disease and treatment-specific outcomes. Antiobesity medications, endoscopic bariatric therapies, and even bariatric surgery may be effective and well tolerated in selected patients with IBD. Summary The intersection of obesity and IBD presents a significant clinical challenge, with obesity influencing the natural history of IBD and potentially affecting treatment efficacy. As obesity prevalence among IBD patients rises, a tailored approach to management is crucial, taking into account the individualized risks and benefits of various treatment strategies, including lifestyle interventions, pharmacotherapy, endoscopic procedures, and bariatric surgery.

show abstract

Section: Bariatric Surgeriesmentioning

confidence: 70%

Section: Bariatric Surgeriesmentioning

confidence: 72%

Section: Bariatric Surgeriesmentioning

confidence: 97%

See 1 more Smart Citation

Reviewing the impact of obesity on inflammatory bowel disease and considerations for optimizing management

Ghusn,

Loftus,

Johnson

2024

Current Opinion in Gastroenterology

View full text Add to dashboard Cite

show abstract

“…Historically, the presence of Crohn disease (CD) was seen as a relative contraindication to undergoing MBS 39 . A recent meta-analysis showed both ulcerative colitis and CD was associated with higher odds of gastric outlet obstruction after RYGB, and CD was associated with increased odds of small bowel obstruction 40 . This highlights the importance of exploring alternative approaches, such as LTA for HH repair and GERD management in specific patient cohorts.…”

Section: Discussionmentioning

confidence: 99%

Ligamentum Teres Augmentation for Hiatus Hernia Repair After Bariatric Surgery: A Systematic Review and Meta-analysis

Chaudhry,

Farsi,

Nakanishi

et al. 2024

Surgical Laparoscopy, Endoscopy &Amp; Percutaneous Techniques

View full text Add to dashboard Cite

Objective: Hiatal hernia (HH) and symptomatic gastroesophageal reflux disease are common complications after metabolic bariatric surgery. This meta-analysis aims to investigate the safety and efficacy of ligamentum teres augmentation (LTA) for HH repair after metabolic and bariatric surgeries (MBS). Materials and Methods: CENTRAL, Embase, PubMed, and Scopus were searched for articles from their inception to September 2023 by 2 independent reviewers using the Preferred Reporting Items for Systematic Reviews and Meta-analysis system. Results: Five studies met the eligibility criteria, with a total of 165 patients undergoing LTA for HH repair after MBS. The distribution of patients based on surgical procedures included 63% undergoing sleeve gastrectomy, 21% Roux-en-Y gastric bypass, and 16% having one anastomosis gastric bypass. The pooled proportion of reflux symptoms before LTA was 77% (95% CI: 0.580-0.960; I 2 = 89%, n = 106). A pooled proportion of overall postoperative symptoms was 25.6% (95% CI: 0.190-0.321; I 2 = 0%, n = 44), consisting of reflux at 14.5% (95% CI: 0.078-0.212; I 2 = 0%, n = 15). The pooled proportion of unsuccessful LTA outcomes was 12.5% (95% CI: 0.075-0.175; I 2 = 0%, n = 21). Conclusion: Our meta-analysis demonstrated that LTA appears to be a safe and efficacious procedure in the management of HH after MBS.

show abstract

“…Suitable patients . According to our opinion, sleeve gastrectomy can be suitable for patients with BMI 30–40 kg/m 2 , especially in those with an expected need for future access to the biliary tree, chronic abdominal pain, or inflammatory bowel disease [58, 59].…”

Section: Treatment Optionsmentioning

confidence: 99%

Obesity treatment in adolescents and adults in the era of personalized medicine

Sundbom,

Järvholm,

Sjögren

et al. 2024

J Intern Med

View full text Add to dashboard Cite

In this multi‐professional review, we will provide the in‐depth knowledge required to work in the expanding field of obesity treatment. The prevalence of obesity has doubled in adults and quadrupled in children over the last three decades. The most common treatment offered has been lifestyle treatment, which has a modest or little long‐term effect. Recently, several new treatment options—leading to improved weight loss—have become available. However, long‐term care is not only about weight loss but also aims to improve health and wellbeing overall. In the era of personalized medicine, we have an obligation to tailor the treatment in close dialogue with our patients. The main focus of this review is new pharmacological treatments and modern metabolic surgery, with practical guidance on what to consider when selecting and guiding the patients and what to include in the follow‐up care. Furthermore, we discuss common clinical challenges, such as patients with concurrent eating disorder or mental health problems, and treatment in the older adults. We also provide recommendations on how to deal with obesity in a non‐stigmatizing way to diminish weight stigma during treatment. Finally, we present six microcases—obesity treatment for persons with neuropsychiatric disorders and/or intellectual disability; obesity treatment in the nonresponsive patient who has “tried everything”; and hypoglycemia, abdominal pain, and weight regain after metabolic surgery—to highlight common problems in weight‐loss treatment and provide personalized treatment suggestions.

show abstract

Bariatric surgery improves outcomes of hospitalizations for acute heart failure: a contemporary, nationwide analysis

Cited by 10 publications

References 28 publications

Reviewing the impact of obesity on inflammatory bowel disease and considerations for optimizing management

Reviewing the impact of obesity on inflammatory bowel disease and considerations for optimizing management

Ligamentum Teres Augmentation for Hiatus Hernia Repair After Bariatric Surgery: A Systematic Review and Meta-analysis

Obesity treatment in adolescents and adults in the era of personalized medicine

Contact Info

Product

Resources

About